Previous Page  129 / 300 Next Page
Information
Show Menu
Previous Page 129 / 300 Next Page
Page Background

Annual Report 2016-17

129

[vii.

American Depository Receipts / Global Depository Receipts / Warrants

As on March 31, 2017, the Company has no American Depository Receipts / Global Depository Receipts / :arrants or any

such convertible instruments outstanding and there is no likely impact on the Company’s Equity Shares in the onancial

year 2016-17.

[viii.

Plant locations

The Company is in software business and does not require manufacturing plants. However, it has software development

centers / ofoces in India and abroad. The addresses of global development centers / ofoces of the Company are given

elsewhere in the Annual Report.

[i[.

Calendar for declaring the onancial statements for the quarters in the onancial year 2017-18 (tentative and

subject to change)

Quarter Ending

Proposed date of meeting of the Board

June 30, 2017

July 20 and July 21, 2017

September 30, 2017

October 15 and October 16, 2017

December 31, 2017

January 19, 2018 and January 20, 2018

March 31, 2018

April 20, 2018 and April 21, 2018

11. ESOP Schemes of the Company

The status of various ESOP schemes as on March 31, 2017 is shown in the following table:

Scheme

i

ii

iii

iv

v

vi

vii

viii

ix

x

xi

xii

Total

Granted

a 4,560,500 753,200 2,533,300 6,958,250 1,890,525 1,216,250 1,784,975 42,000 1,374,462 3,062,272 492,000 67,300 24,735,034

Vested

b 3,214,785 477,085 1,694,802 4,704,472 1,333,792 785,750 796,455 28,000 914,710 2,236,617

-

-

16,186,468

E[ercised

c 3,208,202 472,482 1,455,975 3,876,528 1,217,346 785,750 740,568 28,000 750,933 1,247,970

-

-

13,783,754

Vested but not

e[ercised (b - c)

d

6,583 4,603 238,827 827,944 116,446

-

55,887

-

163,777 988,647

-

-

2,402,714

/apsed

e 1,345,715 276,115 838,498 2,253,778 556,733 430,500 988,520 14,000 459,752 825,655 89,400

-

8,078,666

Not Vested

(a - c - d - e)

f

-

-

-

-

-

-

-

-

-

- 402,600 67,300 469,900

Total Outstanding

(d + f)

g

6,583 4,603 238,827 827,944 116,446

-

55,887

-

163,777 988,647 402,600 67,300 2,872,614

:eighted average

remaining contractual

life

Note(i)

4.46 Note(i)

5.84 Note(i)

-

5.57

-

6.03

1.51

1.25

0.25

:eighted Average

fair value of options

granted (in

`

)

4.69

19.55

26.12

37.38 24.64 25.06 36.97

48.21

54.74 202.70 583.66 700.50

*Note(i): No Contractual life is deoned in the scheme

12. CEO/CFO certiocation

As required by Regulation 17(8) of the /isting Regulations 2015, the CEO/CFO certiocation is provided elsewhere in this

Annual Report.

13. Corporate Governance Handbook

The Company has proactively and voluntarily prepared the Corporate Governance Handbook encompassing set of

guidelines and policies with respect to composition of the Board of Directors and Committees of the Board, meetings

of the Board of Directors and Committees of the Board, Managerial Remuneration, Code of Conduct, :histle Blower

Policy, Risk Management Policy, Internal Control Procedures etc., being adhered to by the Company. The Corporate

Governance Handbook is updated on an annual basis.